Frédéric Coutant
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Atherosclerosis and Cardiovascular Diseases
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Rheumatology 10
- Rheumatoid Arthritis Research and Therapies 8
- Systemic Lupus Erythematosus Research 2
-
- Immunotherapy and Immune Responses 8
- Immune Response and Inflammation 4
- Atherosclerosis and Cardiovascular Diseases 3
- Co-authors
- Pierre Miossec (8 shared papers)Didier Métivier (1 shared paper)Gérard Pierron (1 shared paper)Antoine Tesnière (1 shared paper)E Pichard (1 shared paper)Carmen Garrido (1 shared paper)Sandra Hervás‐Stubbs (1 shared paper)Marie O. Péquignot (1 shared paper)
In The Last Decade
Frédéric Coutant
31 papers receiving 2.4k citations
Frédéric Coutant's Hit Papers
Peers
Comparison fields: 5 of 86
- Immunology 1k
- Oncology 492
- Biological Psychiatry 26
- Rheumatology 136
- Biomaterials 115
Countries citing papers authored by Frédéric Coutant
This map shows the geographic impact of Frédéric Coutant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Coutant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Coutant more than expected).
Fields of papers citing papers by Frédéric Coutant
This network shows the impact of papers produced by Frédéric Coutant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Coutant. The network helps show where Frédéric Coutant may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Coutant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death Hit paper breakdown → | 2005 | 1330 |
| 2 | Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies Hit paper breakdown → | 2021 | 181 |
| 3 | 2001 | 119 | |
| 4 | 2016 | 107 | |
| 5 | 2002 | 81 | |
| 6 | 2006 | 80 | |
| 7 | 2019 | 65 | |
| 8 | 2008 | 64 | |
| 9 | 2004 | 61 | |
| 10 | 2005 | 52 | |
| 11 | 2004 | 48 | |
| 12 | 2009 | 45 | |
| 13 | 2019 | 44 | |
| 14 | 2022 | 30 | |
| 15 | 2012 | 26 | |
| 16 | 2022 | 25 | |
| 17 | 2021 | 24 | |
| 18 | 2023 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2021 | 13 |
About Frédéric Coutant
Frédéric Coutant is a scholar working on Rheumatology, Immunology, Epidemiology, Virology and Pathology and Forensic Medicine, having authored 33 papers that have together received 2.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Immunotherapy and Immune Responses (8 papers), Inflammatory Myopathies and Dermatomyositis (6 papers), Immune Response and Inflammation (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Systemic Sclerosis and Related Diseases (2 papers), HIV Research and Treatment (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Immunology (1k citations), Oncology (492 citations), Biological Psychiatry (26 citations), Rheumatology (136 citations) and Biomaterials (115 citations). Frédéric Coutant has collaborated with scholars based in France and Belgium. Frequent co-authors include Pierre Miossec, Didier Métivier, Gérard Pierron, Antoine Tesnière, E Pichard, Carmen Garrido, Sandra Hervás‐Stubbs, Marie O. Péquignot, Noëlia Casares and François Ghiringhelli. Their work appears in journals such as PLoS ONE, The Journal of Immunology, Lara D. Veeken, International Journal of Molecular Sciences and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.